NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/viatris-inc. Investors have until June 3, 2025, to ask the Court to be appointed to lead the case. ...

NEW YORK, May 1, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS).Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/viatris-inc-loss-submission-form-2/?id=146170&from=4CLASS PERIOD: August 8, 2024 to February 2 ...

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Viatris investors who were adversely affected by alleged securities fraud between August 8, 2024 and February 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/viatris-inc-lawsuit-submissio ...

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/viatris-inc. Why was Viatris Sued for Securities Fraud? Viatris is a global healthcare company t ...

NEW YORK, April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Viatris investors who were adversely affected by alleged securities fraud between August 8, 2024 and February 26, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form ...

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS). Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/viatris-inc-loss-submission-form-2/?id=145083&from=3 CLASS PERIOD: August 8, 2024 to ...

NEW YORK, April 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS).Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/viatris-inc-loss-submission-form-2/?id=145061&from=4CLASS PERIOD: August 8, 2024 to Februar ...

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/viatris-inc. Investors have until June 3, 2025, to ask the Court to be appointed to lead the cas ...

文章核心观点 罗森律师事务所提醒在2024年8月8日至2025年2月26日期间购买维阿特里斯公司证券的投资者，2025年6月3日是主要原告截止日期，符合条件的投资者可通过风险代理安排获得赔偿 [1] 案件详情 - 诉讼称在集体诉讼期间被告向投资者提供维阿特里斯印度印多尔工厂检查失败的重大信息，包括FDA发出警告信和进口警报，虽提及影响但称是“小逆风” [4] - 被告在披露信息时传播虚假误导性陈述或隐瞒警告信对维阿特里斯财务真实影响的重大不利事实，未披露检查时间、整改时长、财务影响等内容，导致原告和其他股东以虚高价格购买证券，市场获知真实细节后投资者受损 [5] 参与集体诉讼方式 - 可访问https://rosenlegal.com/submit-form/?case_id=36783 ，或致电866 - 767 - 3653联系Phillip Kim律师，或发邮件至case@rosenlegal.com获取更多信息 [2][6] 选择罗森律师事务所原因 - 鼓励投资者选择有成功记录的合格律师，很多发布通知的公司无相关经验、资源和同行认可，只是中介，而罗森律师事务所代表全球投资者，专注证券集体诉讼和股东派生诉讼 [3] - 该律所曾达成针对中国公司有史以来最大的证券集体诉讼和解，2017年证券集体诉讼和解数量被ISS证券集体诉讼服务机构评为第一，自2013年起每年排名前四，为投资者追回数亿美元，2019年为投资者获得超4.38亿美元赔偿，2020年创始合伙人被评为原告律师界巨头，多位律师获行业认可 [3]

文章核心观点 领先证券法律事务所Bleichmar Fonti & Auld LLP宣布对Viatris公司及其部分高管提起诉讼，指控其违反联邦证券法，投资者可通过特定链接获取信息并在规定时间内申请牵头此案 [1][2] 诉讼相关情况 - 律所鼓励Viatris投资者访问指定链接获取更多信息，投资者需在2025年6月3日前请求法院指定其牵头案件，案件依据1934年《证券交易法》第10(b)和20(a)条代表购买Viatris证券的投资者提出索赔，目前案件在美国宾夕法尼亚西区地方法院审理 [2] 被诉原因 - Viatris是一家全球医疗保健公司，为超165个国家和地区约10亿患者提供药品，公司曾称其设施处于“良好运行状态”，适合预期用途并致力于维持最高质量制造标准，但2024年12月23日公司透露美国食品药品监督管理局（FDA）因印度印多尔工厂检查失败发出警告信，不过公司淡化了该情况 [3] - FDA检查失败对公司财务结果造成重大不利影响，导致公司无法生产和分销包括来那度胺在内的关键产品 [4] 股价影响 - 2025年2月27日公司公布2024年第四季度业绩和2025年指引，称印多尔工厂检查失败的“负面影响”将使2025年营收减少约5亿美元，运营利润减少约3.85亿美元，且该工厂检查失败使其无法为来那度胺确定替代供应方案及获得FDA更多产品豁免，消息传出当天Viatris股价下跌约15%，从2月26日收盘价每股11.24美元降至2月27日每股9.53美元 [5] 投资者行动建议 - 若投资者投资了Viatris，可能有法律途径，鼓励向律所提交信息，代理采用风险代理收费模式，投资者无需承担任何诉讼费用，律所将寻求法院批准潜在费用和开支 [6] - 投资者可通过访问指定链接或联系特定人员提交信息 [7][8] 律所介绍 - Bleichmar Fonti & Auld LLP是一家领先的国际法律事务所，代表证券集体诉讼和股东诉讼的原告，2023年被ISS SCAS评为前5名原告律师事务所，其律师被Law360评为“原告律师界巨头”，被汤森路透评为“超级律师” [8] - 该律所近期显著成果包括从特斯拉董事会追回超9亿美元价值，从梯瓦制药工业有限公司追回4.2亿美元 [9]